News
Behavioral variability is quietly sabotaging clinical trials—but it doesn't have to. Here's how predictive behavioral modeling can improve trial design, reduce dropout, and deliver more inclusive, ...
Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the ...
Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and ...
Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...
Some of Sanofi’s most high-profile readouts this year can’t have made for easy reading at the French pharma’s Paris ...
ABBOTT PARK, Ill., April 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) has announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months for patients receiving ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...
Pharmaceuticals announced the presentation of clinical data from the company’s Phase 2b PROGRESS study for its investigational, ...
A majority of cancer drugs approved in the US during 2019-2022 had “clinical trial uncertainties,” research suggests.
Pfizer (PFE) and Moderna (MRNA) reveal trial data showing their updated COVID mRNA vaccines are safe and effective after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results